bpc 157 pharmacokinetics half life study Pharmacokinetics, distribution, metabolism, and excretion of body-protective compound 157, a potential drug for treating various wounds, in rats and dogs Frontiers | Stable Gastric Pentadecapeptide

This is highly speculative because: Oral bioavailability differs between species Route of administration affects systemic exposure Species differences in peptide metabolism and clearance are unknown Current Practice Patterns Current practice patterns from unregulated sources typically involve: Subcutaneous injection: 0.25-0.5 mg once or twice daily, administered near injection sites for localized effects or abdominally for systemic distribution

Convenient to bundle in the same order Pharmacies available at some compounding pharmacies

I sound so sad, bad and mad Thanks Top of arm is best and they hurt no more than any other injection might...but the benefit is worth a tiny scratch

Systematic comparative data is limited, but the hypothesis is supported by general peptide chemistry principles around salt form and stability

That's what I felt, man